相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Off-Target In Vitro Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent
Yili Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
Anthony Touafchia et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19)
Carlo Pallotto et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Cell surface markers for immunophenotyping human pluripotent stem cell-derived cardiomyocytes
Kenneth R. Boheler et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: Therapeutic potential of Drpitor1 and Drpitor1a in cancer and cardiac ischemia-reperfusion injury
Danchen Wu et al.
FASEB JOURNAL (2020)
Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
David T. Paik et al.
PHARMACOLOGICAL REVIEWS (2020)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
The cell surface marker CD36 selectively identifies matured, mitochondria-rich hPSC-cardiomyocytes
Ellen Ngar-Yun Poon et al.
CELL RESEARCH (2020)
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
Wanchao Yin et al.
SCIENCE (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Potential Effects of Coronaviruses on the Cardiovascular System A Review
Mohammad Madjid et al.
JAMA CARDIOLOGY (2020)
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Shaobo Shi et al.
JAMA CARDIOLOGY (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19
Sarah C. J. Jorgensen et al.
PHARMACOTHERAPY (2020)
Why COVID-19 Silent Hypoxemia Is Baffling to Physicians
Martin J. Tobin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19
Rajendran J. C. Bose et al.
DRUG DISCOVERY TODAY (2020)
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
Liuliu Yang et al.
CELL STEM CELL (2020)
The association between cardiac injury and outcomes in hospitalized patients with COVID-19
Shahrokh Karbalai Saleh et al.
INTERNAL AND EMERGENCY MEDICINE (2020)
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)
Valentina O. Puntmann et al.
JAMA CARDIOLOGY (2020)
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes
Seong Woo Choi et al.
ANTIVIRAL RESEARCH (2020)
Association Between Hypoxemia and Mortality in Patients With COVID-19
Jiang Xie et al.
MAYO CLINIC PROCEEDINGS (2020)
SARS-CoV-2 infects and induces cytotoxic effacts in human cardiomyocytes
Denisa Bojkova et al.
CARDIOVASCULAR RESEARCH (2020)
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Brandi N. Williamson et al.
NATURE (2020)
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury
Chun-Ka Wong et al.
CIRCULATION JOURNAL (2020)
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
Andrea J. Pruijssers et al.
CELL REPORTS (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection
Radha Gopal et al.
FRONTIERS IN IMMUNOLOGY (2020)
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
Sawittree Sahakijpijarn et al.
PHARMACEUTICS (2020)
Cardiovascular Manifestations of COVID-19 Infection
Ajit Magadum et al.
CELLS (2020)
Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection
Arun Sharma et al.
CELL REPORTS MEDICINE (2020)
Cardiovascular disease and COVID-19
Manish Bansal
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Egor P. Tchesnokov et al.
VIRUSES-BASEL (2019)
Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing
Gary Gintant et al.
CIRCULATION RESEARCH (2019)
Fatty Acids Enhance the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
Xiulan Yang et al.
STEM CELL REPORTS (2019)
Integrated transcriptomic and regulatory network analyses identify microRNA-200c as a novel repressor of human pluripotent stem cell-derived cardiomyocyte differentiation and maturation
Ellen Ngar-yun Poon et al.
CARDIOVASCULAR RESEARCH (2018)
Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems
Tarek Magdy et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Differential temporal inhibition of mitochondrial fission by Mdivi-1 exerts effective cardioprotection in cardiac ischemia/reperfusion injury
Chayodom Maneechote et al.
CLINICAL SCIENCE (2018)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus
Joy Y. Feng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes
Natalie Weber et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia-Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction
Ayako Ishikita et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Proteomic Analysis of Human Pluripotent Stem Cell-Derived, Fetal, and Adult Ventricular Cardiomyocytes Reveals Pathways Crucial for Cardiac Metabolism and Maturation
Ellen Poon et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C
Tariq Ahmad et al.
HEPATOLOGY (2015)
Proteomic Analysis of Human Pluripotent Stem Cell-Derived, Fetal, and Adult Ventricular Cardiomyocytes Reveals Pathways Crucial for Cardiac Metabolism and Maturation
Ellen Poon et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
Mitochondrial dynamics and mitochondrial quality control
Hong-Min Ni et al.
REDOX BIOLOGY (2015)
Mitochondrial Dynamics - Mitochondrial Fission and Fusion in Human Diseases
Stephen L. Archer
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Transcriptome-Guided Functional Analyses Reveal Novel Biological Properties and Regulatory Hierarchy of Human Embryonic Stem Cell-Derived Ventricular Cardiomyocytes Crucial for Maturation
Ellen Poon et al.
PLOS ONE (2013)
Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor
Mayel Gharanei et al.
PLOS ONE (2013)
Mitochondrial division/mitophagy inhibitor (Mdivi) Ameliorates Pressure Overload Induced Heart Failure
Srikanth Givvimani et al.
PLOS ONE (2012)
Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition
Nadezda Apostolova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization
Ann Cassidy-Stone et al.
DEVELOPMENTAL CELL (2008)
Adenosine 3 ',5 '-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors
Kaleb C. Lund et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells
E Smirnova et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
分享论文
